Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FBNC | RXRX |
|---|---|---|
| Price | $61.79 | $4.78 |
| Change today | ▼ 0.87% | ▲ 16.02% |
| Market cap | $2.56B | $2.56B |
| Return, 3 months | -1.8% | +24.5% |
| Return, year to date | +23.1% | +16.9% |
| Return, 1 year | +21.0% | -13.6% |
| P/E (TTM) | 19.2 | -4.8 |
| P/B | 1.5 | 2.8 |
| P/E percentile vs own 5y | – | 49th |
| Dividend yield | 1.52% | – |
| Revenue growth (YoY, latest qtr) | +14.9% | – |
| Net profit growth (YoY) | +31.0% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 40.2% | – |
| Return on equity | – | – |
| Analyst target vs. price | +13.3% | +39.1% |
| Analyst buy share | 67% | 40% |
| RSI (14) | 43 | 72 |
| 30-day volatility | 18.8% | 89.6% |
| Max drawdown, 1 year | -15.3% | -58.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
